−0.153SEK
−44.05 MSEK
About ANNEXIN PHARMACEUTICALS AB
Sector
CEO
Nils Anders Haegerstrand
Headquarters
Stockholm
Website
Employees (FY)
4
Founded
2014
ISIN
SE0009664154
FIGI
BBG00GGV2H53
Annexin Pharmaceuticals AB operates as a biotechnology company. It develops treatment of various cardiovascular diseases. The firm establishes and optimizes a cell line for large-scale production of Annexin A5. The company was founded by Anna Frostegård in 2014 and is headquartered in Stockholm, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ANNX is 0.28 SEK — it has increased by 1.82% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ANNEXIN PHARMACEUTICALS AB stocks are traded under the ticker ANNX.
Yes, you can track ANNEXIN PHARMACEUTICALS AB financials in yearly and quarterly reports right on TradingView.
Like other stocks, ANNX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANNEXIN PHARMACEUTICALS AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 4.00 employees. See our rating of the largest employees — is ANNEXIN PHARMACEUTICALS AB on this list?